These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 16603015)

  • 1. Renal protective agents: a review.
    Duke GJ
    Crit Care Resusc; 1999 Sep; 1(3):265-75. PubMed ID: 16603015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal replacement therapy in the intensive care unit.
    Bellomo R; Ronco C
    Crit Care Resusc; 1999 Mar; 1(1):13-24. PubMed ID: 16599859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment of acute renal failure using diuretics and/or low ("Renal") dose of dopamine: a critical review.
    McLigeyo SO
    Afr J Health Sci; 1997; 4(1):2-8. PubMed ID: 17583971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of postoperative acute renal failure.
    Reddy VG
    J Postgrad Med; 2002; 48(1):64-70. PubMed ID: 12082335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal-dose (low-dose) dopamine for the treatment of sepsis-related and other forms of acute renal failure: ineffective and probably dangerous.
    Power DA; Duggan J; Brady HR
    Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S23-8. PubMed ID: 10386250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
    Waring WS; Moonie A
    Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
    Brienza N; Malcangi V; Dalfino L; Trerotoli P; Guagliardi C; Bortone D; Faconda G; Ribezzi M; Ancona G; Bruno F; Fiore T
    Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
    Heintz BH; Matzke GR; Dager WE
    Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of renal replacement therapy in critically ill patients with acute kidney injury.
    Bouman CS; Oudemans-van Straaten HM
    Curr Opin Crit Care; 2007 Dec; 13(6):656-61. PubMed ID: 17975386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of drug-induced acute kidney injury.
    Pannu N; Nadim MK
    Crit Care Med; 2008 Apr; 36(4 Suppl):S216-23. PubMed ID: 18382197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring intestinal ischaemia.
    Corke C; Glenister K
    Crit Care Resusc; 2001 Sep; 3(3):176-80. PubMed ID: 16573500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal-dose dopamine: from hypothesis to paradigm to dogma to myth and, finally, superstition?
    Jones D; Bellomo R
    J Intensive Care Med; 2005; 20(4):199-211. PubMed ID: 16061903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute renal failure: prevention and nondialytic therapy.
    Vijayan A; Miller SB
    Semin Nephrol; 1998 Sep; 18(5):523-32. PubMed ID: 9754605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute kidney failure in critically ill patients and its prevention].
    Krouzecký A; Rokyta R; Matĕjovic M; Novák I
    Cas Lek Cesk; 2003 Jan; 142(1):19-23; discussion 23-4. PubMed ID: 12693293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin--a review of its role in the management of traumatic brain injury.
    Roberts RG; Redman JW
    Crit Care Resusc; 2002 Dec; 4(4):271-80. PubMed ID: 16573440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin in the critically ill patient.
    Worthley LI; Holt AW
    Crit Care Resusc; 1999 Sep; 1(3):252-64. PubMed ID: 16603014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive drugs and the importance of renal perfusion pressure.
    Bersten AD; Holt AW
    New Horiz; 1995 Nov; 3(4):650-61. PubMed ID: 8574595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.